These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 14711364)

  • 1. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
    Fernández LE; Alonso DF; Gomez DE; Vázquez AM
    Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NGcGM3 ganglioside: a privileged target for cancer vaccines.
    Fernandez LE; Gabri MR; Guthmann MD; Gomez RE; Gold S; Fainboim L; Gomez DE; Alonso DF
    Clin Dev Immunol; 2010; 2010():814397. PubMed ID: 21048926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotype antibodies in cancer treatment.
    de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
    Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody.
    Talavera A; Eriksson A; Okvist M; López-Requena A; Fernández-Marrero Y; Pérez R; Moreno E; Krengel U
    Mol Immunol; 2009 Oct; 46(16):3466-75. PubMed ID: 19748674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody.
    Chapman PB
    Curr Opin Investig Drugs; 2003 Jun; 4(6):710-5. PubMed ID: 12901230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
    Bendandi M
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):65-72. PubMed ID: 12113135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Past, present and future of anti-idiotype vaccination].
    Rodríguez Calvillo M; Inogés S; López Díaz de Cerio A; Zabalegui N; Panizo C; Hernández M; Pérez Calvo J; Prósper F; Melero I; Sánchez-Ibarrola A; Rocha E; Bendandi M
    Rev Med Univ Navarra; 2004; 48(3):14-23. PubMed ID: 15622921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-idiotype vaccine against cancer.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides, Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype system.
    López-Requena A; De Acosta CM; Moreno E; González M; Puchades Y; Talavera A; Vispo NS; Vázquez AM; Pérez R
    Mol Immunol; 2007 Jan; 44(4):423-33. PubMed ID: 16581129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Bhattachary-Chatterjee M; Nath Baral R; Chatterjee SK; Das R; Zeytin H; Chakraborty M; Foon KA
    Cancer Immunol Immunother; 2000 Jun; 49(3):133-41. PubMed ID: 10881692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
    Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
    Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
    Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
    Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigens for cancer immunotherapy.
    Neller MA; López JA; Schmidt CW
    Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of anti-idiotypic antibodies in the treatment of solid tumors in humans.
    Euhus DM; Wong JH
    Surg Gynecol Obstet; 1992 Jul; 175(1):89-96. PubMed ID: 1621207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial.
    Neninger E; Díaz RM; de la Torre A; Rives R; Díaz A; Saurez G; Gabri MR; Alonso DF; Wilkinson B; Alfonso AM; Combet T; Pérez R; Vázquez AM
    Cancer Biol Ther; 2007 Feb; 6(2):145-50. PubMed ID: 17218777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer.
    Gajdosik Z
    Drugs Today (Barc); 2014 Apr; 50(4):301-7. PubMed ID: 24918647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
    Brockstedt DG; Dubensky TW
    Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.